Ryan Kelly is Chief Communications Officer at Recursion, the leading TechBio with a mission to fundamentally change the way drugs are discovered. Since joining Recursion three years ago, he has led the company’s internal and external communications through key pipeline updates, partnership milestones with NVIDIA, Bayer, Roche & Genentech, and its combination with two private companies and with Exscientia – the largest M&A deal inTechBio. Internally at Recursion, Ryan was the executive sponsor for the launch of the company’s first ERG program, which has evolved into a Pride ERG, a women’s ERG and a people of color ERG.
Ryan has deep expertise driving communications that share the impact of cutting-edge technologies, having previously served as Vice President of Marketing and Communications, Hyperloop, at the Virgin Group. Earlier in his career, he held in-house and agency roles in digital advertising and creative, including as a partner at GW New York and Catch24 serving clients like Bosch, Salesforce, Oracle, PwC, and Lufthansa, and on the digital team at The New York Times.
Ryan served as a General Assembly instructor across digital strategy, data, and analytics for nearly a decade, and advises multiple startups looking for marketing and communications support. He is currently a board member for both Ballet West and Equality Utah.
